Tranexamic Acid Injection, Solution
Product Images NDC 25021-418

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 25021-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra1f 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Bag Label (Tra1f 0000 02)

Package Label – Principal Display Panel – Bag Label (Tra1f 0000 02)
This is a description for a medication in a single-dose container containing 100mL of a solution of 1000mg of Tranexamic Acid and 7mg of Sodium Chloride per 100mL. The solution is for intravenous infusion only and is sterile, nonpyrogenic, preservative-free, PVC-free, and DEHP-free. It is not made with natural rubber latex. Dosage information can be found in the prescribing information. It is important to check for leaks before using, not to add other medications, and not to use in series connections. The storage instructions specify a temperature range of 20° to 25°C. The medication is manufactured by SAGENT Pharmaceuticals in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.